JWM
ORIC icon

JPL Wealth Management’s Oric Pharmaceuticals ORIC Stock Holding History

JPL Wealth Management’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05K Buy
97
+2
+2% +$18 ﹤0.01% 1279
2026
Q1 		$1.2K Buy
+95
New +$1.08K ﹤0.01% 1146
2025
Q4 		– Sell
-95
Closed -$1.14K – 808
2025
Q3 		$1.14K Buy
+95
New +$999 ﹤0.01% 977

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JPL Wealth Management's ORIC Position: Q2 2026 in Review

JPL Wealth Management increased its Oric Pharmaceuticals (ORIC) stake by 2.1% in Q2 2026, buying an estimated $18 and bringing the position to 97 shares worth $1.05K. The position accounts for ﹤0.01% of the portfolio, ranked #1279.

JPL Wealth Management first reported a position in ORIC in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.2K in Q1 2026. 181 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • JPL Wealth Management held 97 shares of Oric Pharmaceuticals worth $1.05K as of Q2 2026.
  • JPL Wealth Management bought 2 Oric Pharmaceuticals shares in Q2 2026, an estimated $18.
  • Oric Pharmaceuticals made up ﹤0.01% of JPL Wealth Management's portfolio in Q2 2026, its #1279 holding.
  • JPL Wealth Management first reported a position in Oric Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • JPL Wealth Management's Oric Pharmaceuticals position peaked at $1.2K in Q1 2026.
  • 181 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on JPL Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.